Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Phase 4

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07251790Not ApplicableRecruiting

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

Role: collaborator

NCT06975189Phase 2Recruiting

MINImising Total Radiation EXposure in Preterm Infants

Role: lead

NCT07101419Not ApplicableNot Yet Recruiting

Speed of Lung Inflation During Ventilation of Extremely Preterm Infants

Role: collaborator

NCT05366153Recruiting

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer

Role: collaborator

NCT06279260Recruiting

National Robotics-Assisted Radical Prostatectomy Database

Role: collaborator

NCT03333278Phase 2Completed

The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial

Role: collaborator

NCT02835040Not ApplicableCompleted

IMPROVinG Outcomes in Community Acquired Pneumonia

Role: lead

NCT01763242Phase 4Completed

Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease

Role: lead

All 8 trials loaded